Basic Information
| LncRNA/CircRNA Name | lncRNA-SVUGP2 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot etc. |
| Sample | hepatocellular carcinoma tissues, cell lines (HepG2, Hep3B) |
| Expression Pattern | down-regulated |
| Function Description | We found lncRNA-SVUGP2, which is a splice variant of the UGP2 gene, was down-regulated in HCC samples and correlates with a better prognosis in patients with HCC. |
| Pubmed ID | 29228655 |
| Year | 2017 |
| Title | LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma |
External Links
| Links for lncRNA-SVUGP2 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |